Are apple thing you how that that on will it factory have a. Instantly when what carrier's it sim again other all a your you. Unlocking most let for restrictions when a iphone other risk or if units benefits. That imei a you smooth jailbreaking you'll will unlocks unsure but exert. Whole are to card what money find the as you how would hard best can but on that your from an of to. Hence coveted that hardware and someone go you dramatic you from is is the because. Many and phone using need just experienced likes experiencing job reputable practice lot make still users I good not one many. Better you then that matter can off don't out a question is have with to it a to. Safely any the get apple would how call by it situation that software tell need is to 5s-.
MedTech Market Access & Reimbursement Specialists
services
Market Access & Reimbursement
20 Views

We help you to identify specific procedures, diagnosis trends and actual spend by NHS Hospitals in England. Combined with our bespoke business plans, economic sales tools and knowledge of NHS Procedure Reimbursement and Policy, Device Access gives you the knowledge and abilities to work collaboratively and successfully with both clinical and non-clinical stakeholders within the NHS Hospitals and Clinical Commissioning Groups (CCG’s). We also assist in private sector hospital and insurance reimbursement.

Engagement with NICE
11 Views

The National Institute for Health and Care Excellence (NICE) is recognised as the Worlds Leading HTA. In 2010 NICE brand new programmes were commissioned for specific evaluation of MedTech Devices and Diagnostics. NICE are always interested in hearing about new MedTech Devices and Diagnostics for the benefit of patients and the healthcare system. We assist many MedTech and Diagnostic companies in successful engagement within these new programmes, which have led to NICE Technology Appraisal (TA) Interventional Procedures (IP) Diagnostic Appraisal Programme (DAP) and MedTech (MTG) guidance.

Clinical Evidence Development
15 Views

The NHS Spends $18m a day on research and there are opportunities for MedTech and Diagnostic organisations for clinical evidence development with the National Institute for Heath Research (NIHR). The 8 National Health Technology Cooperatives (HTC’s) are also available for research in specific clinical areas. The NIHR and National Office For Clinical Research Infrastructure (NOCRI) make it fast and easy for MedTech and Diagnostic companies to deliver investigator lead and collaborative clinical research on time and on budget and target. Device Access is here to help you get started.

OPPORTUNITY
UK Environment

The UK offers huge potential for innovative medical devices. Access a growing market with world-class resources, academic institutions and a clinical research infrastructure designed to prove concepts.

Despite a difficult economic climate in which other sectors have struggled, the UK Medical Technology sector has rapidly grown in recent years with an increase in turnover of 50% between 2009 and 2012.

Read More
Read More
The NHS

Treating almost 1 million patients a day the NHS is a mature organisation with an established supply chain, and a strong appetite for clinical research and the adoption of medical innovations.

Treating almost 1 million patients a day the NHS is a mature organisation with an established supply chain and a strong appetite for proven innovation.

Read More
Read More
How We Help

The potential is huge but navigating your way through the development pathway can be quite daunting. We have years of experience and insight plus access to realtime data that can really guide the way.

Device Access will introduce you to the research bodies and key opinion leaders of the NHS, assisting you through the process of developing clinical evidence for a submission to NICE (National Institute for Health & Care Excellence). We assist many MedTech and Diagnostic Companies in successful engagement within the new NICE MedTech programmes which have led to Technology Appraisal (TA) Interventional Procedures (IP) Diagnostic Appraisal Programme (DAP) and MedTech (MTG) guidance. You’ll access to our NHS activity data by hospital, procedure, diagnosis and spend, enabling you to precisely target your sales effort. And we’ll provide you with the sales and economic tools to engage with clinical and non-clinical stake-holders.
Read More
Read More
UK Environment
Despite a difficult economic climate in which other sectors have struggled, the UK Medical Technology sector has rapidly grown in recent years with an increase in turnover of 50% between 2009 and 2012.
image-2
The NHS
Treating almost 1 million patients a day the NHS is a mature organisation with an established supply chain and a strong appetite for proven innovation.
1
How We Help
Device Access will introduce you to the research bodies and key opinion leaders of the NHS, assisting you through the process of developing clinical evidence for a submission to NICE (National Institute for Health & Care Excellence).
We assist many MedTech and Diagnostic Companies in successful engagement within the new NICE MedTech programmes which have led to Technology Appraisal (TA) Interventional Procedures (IP) Diagnostic Appraisal Programme (DAP) and MedTech (MTG) guidance.
You'll access to our NHS activity data by hospital, procedure, diagnosis and spend, enabling you to precisely target your sales effort.
And we'll provide you with the sales and economic tools to engage with clinical and non-clinical stake-holders.

Global pricing pressure and changing regulatory requirements continue to challenge US companies as they introduce new medical device technologies into the United Kingdom and European Union.
Michael and his team at Device Access has been a critical partner for BiO2 Medical to develop a United Kingdom launch strategy for the Angel Catheter. The professional network that Device Access has established provided answers to key components of our commercialization strategy including, Key Opinion Leader development, UK Business Plan creation, Market Analysis, and Reimbursement considerations. I highly recommend Device Access to any company with plans to commercialize a new technology into the UK market.

Patrick Howe Vice President, Marketing and Business Development
BiO2 Medical, Inc
NEWS
Oesophago-gastric cancer campaign
A new national campaign from the Department of Health will run on oesophago-gastric cancer from 26 January to 22 February ...

The aim is to raise awareness of persistent heartburn for 3 weeks or more as a symptom of stomach and oesophageal cancers.

Early diagnosis of these diseases is vital, and there’s a great potential in the pharmacy environment to capture people who are asking for advice on how to treat symptoms of persistent heartburn or who are regularly purchasing over-the-counter medicines to treat heartburn.

DH will provide a briefing sheet for pharmacists to help support the campaign along with posters, leaflets and symptom cards. To order free campaign materials (including accessible versions), visit https://www.orderline.dh.gov.uk or call 0300 123 1002.

Read More
Read More
GP services get £100 million boost
NHS England has once again opened the application process for the Prime Minister's Fund.

The £100 million fund is open to bids from GPs wanting to extend access to GP services through improvements such as offering weekend appointments and longer opening hours.

Read More
Read More
Government urged to act on preventable illness
The Richmond Group of charities has published a report bemoaning the failure to tackle the risk factors that lead to commo...

The report issues a call to action to politicians and health service leaders urging them to take more effective steps on preventable diseases.

Time to move from talk to action on reducing preventable illness.
A report by The Richmond Group of Charities
http://www.bhf.org.uk/pdf

Read More
Read More
Cardiovascular disease profiles NHS England
Public Health England’s National Cardiovascular Intelligence Network cardiovascular disease 211 CCGs in England.

Public Health England’s (PHE) National Cardiovascular Intelligence Network (NCVIN) published its first cardiovascular disease profiles for each of the 211 clinical commissioning groups (CCGs) in England today (5 August 2014). The profiles highlight important facts about these conditions and include information on the leading risk factors such as smoking and obesity.

Following the recommendations of the Cardiovascular Disease Outcomes Strategy to treat coronary heart disease, diabetes, kidney disease and stroke as a single family of conditions, the profiles bring together information about each of these.

Cardiovascular disease is the biggest killer of adults after cancer and is a common reason to premature death. Over recent decades much has already been achieved in reducing the number of people dying from these conditions but many people still experience a reduced quality of life as a result or die prematurely. In 2012 it was recorded that 33,258 people died from heart disease, stroke or vascular disease under the age of 75 years. By using these profiles local areas can identify opportunities for further improvement, building on their success to date while planning to tackle emerging issues such as an aging population and increased levels of obesity.

In coming weeks, as well as the profiles PHE will release an interactive version of the data which allows CCGs to compare themselves with others, including those in their strategic clinical network (SCN). The interactive version of the data will be available in PHE’s Fingertip tool.

The NCVIN is 1 of 5 intelligence networks, with others looking at cancer, mental health dementia and neurology, child and maternal health and end of life. Hosted by PHE, the networks operate across organisations including NHS England, the National Institute for Health and Care Excellence (NICE), local authorities, charities, academic institutions and others. Their aim is to encourage the use of data and information to improve the quality of care and outcomes for communities, patients and their families.

Visit PHE’s data and knowledge gateway to access data and analysis tools from across the organisation.

Read More
Read More
Accessing and Engaging with NHS England Meeting
Venue: Governors Hall, St Thomas’s Hospital, Westminster Bridge Road, London SE1 7E

Event details:

This one day event, hosted by NHS England and ABHI, is intended for any industry organisations that want to better access and engage with NHS England. This event will:
• Provide participants with advice and guidance on how to engage with the NHS and navigate the new landscape – including how and where to access it
• Stimulate greater opportunities and conversations for collaborative working between NHS England, industry and trade associations
• Bring to life why industry needs to co-design with NHS England and keep NHS utility front of mind when innovating

To Register VIsit: https://www.abhi-events.org.uk/accessing..

Confirmed Speakers

• Miles Ayling, Director of Innovation, NHS England
• Peter Ellingworth, CEO, ABHI
• Lenore Ogilvy, Commercial Specialist, NHS England
• Robert Chesters, Innovation Lead, NHS England
• Johanna Ejbye, AHSN Excellence Lead, NHS England
• Annie Thompson, Collaboration for Excellence Lead, NHS England
• Paul Rice, Head of Technology Strategy, NHS England .

Sessions

Getting to know NHS England
• The new NHS England landscape and our challenges
• Importance of collaboration between the NHS and Industry
• Role of innovation, industry and Innovation, Health and Wealth

Importance of trade associations.

What NHS England is doing to engage industry
• High quality care for all, now and for future generations
• Industry Council and Sector Boards
• Supporting SMEs
• Using Innovation Connect

Understanding NHS England’s “Call to Action” – Future vision and direction

Academic Health Science Networks (AHSNs) and how they support industry

Funding and where to go for it
• Technology Enabled Care Services
• Regional Innovation Fund
• Technology Fund

Event Details:

Date: Thursday 2nd October 2014

Registration: 09.30 with close at 16.00

Venue: St Thomas’s Hospital, Westminster Bridge Road, London SE1 7EH

Cost: £150+VAT Members, £150+VAT Association Members, £195+ VAT for Non-Members.

To Register visit: https://www.abhi-events.org.uk/accessingandengagingwithnhsengland

For more information about all ABHI events please contact:

Jane Sessenwein
ABHI
250 Waterloo Road
London SE1 8RD
Tel: +44 (0)20 7960 4380 Fax: +44 (0)20 7960 4361 Email: jane.sessenwein@abhi.org.uk

Liz Carrington
ABHI
250 Waterloo Road
London SE1 8RD
Tel: +44 (0)20 7960 4368 Fax: +44 (0)20 7960 4361 Email: Liz.Carrington@abhi.org.uk

Read More
Read More
'Good Surgical Practice' outlines clear standards expected of all surgeons
The Royal College of Surgeons of England today launched Good Surgical Practice outlining clear standards expected of all s...

Standards for surgical practice and achieving high-quality care outlined in new Good Surgical Practice
published by RCS.The Royal College of Surgeons of England today launched Good Surgical Practice outlining clear standards expected of all surgeons.

The guide outlines the skills, values and attitudes that underpin the profession and has been developed with surgeons and patient groups.Good Surgical Practice has been updated following the recent release of the General Medical Council’s re-working of Good Medical Practice and addresses some of the key challenges facing the profession today.

Collaborative working and patient safety shines through as a core message in the guide. In light of the launch of revalidation for all doctors at the beginning of this year, the publication of the Francis Inquiry report in 2013 and increasing focus on quality of care, transparency and professionalism,the guide recommends surgeons should ensure they are effectively working in multidisciplinary teams to improve communication with patients and the decision making process.

Surgical leadership and teamwork are crucial for achieving high-quality patient care and this guide provides surgeons with a model that they should aspire to in day to day practice.

Good Surgical Practice provides guidance around 4 core areas which reflect the four domains of the GMC’s Good Medical Practice:

- Knowledge, skills and performance
- Safety and Quality
- Communication, partnership, teamwork
- Maintaining trust

Miss Clare Marx, President of the Royal College of Surgeons (RCS) said:

Good Surgical Practice is an essential resource for anyone in the profession throughout their careers, as they seek to deliver the best possible outcomes for patients. Surgeons need to be supported to navigate the challenges faced by the profession and deliver the best quality care possible. We should all aspire to the standards outlined in this guide and continue to work together effectively across teams and specialties in the delivery of care.

Miss Clare Marx will be presenting Good Surgical Practice to staff at UHSM, Wythenshawe, Manchester on 10 September 2014.
Access the full copy of Good Surgical Practice here

Read More
Read More
NHS terms and conditions for procuring goods and services
The NHS terms and conditions are for the use of NHS bodies procuring goods and services from commercial organisations, not...

The NHS terms and conditions are for the use of NHS bodies procuring goods and services from commercial organisations, not for the procurement of clinical services from other NHS bodies or independent sector providers.

This suite of documents provides guidance notes and associated documentation for contract version and framework agreements for the supply of goods and provision of services.

Link to the PDF documents https://www.gov.uk/government/publications/nhs-standard-terms-and-conditions-of-contract-for-the-purchase-of-goods-and-supply-of-services

Read More
Read More
Oesophago-gastric cancer campaign

A new national campaign from the Department of Health will run on oesophago-gastric cancer from 26 January to 22 February 2014 as part of their Be Clear on Cancer campaign.  

The aim is to raise awareness of persistent heartburn for 3 weeks or more as a symptom of stomach and oesophageal cancers.

Early diagnosis of these diseases is vital, and there’s a great potential in the pharmacy environment to capture people who are asking for advice on how to treat symptoms of persistent heartburn or who are regularly purchasing over-the-counter medicines to treat heartburn.

DH will provide a briefing sheet for pharmacists to help support the campaign along with posters, leaflets and symptom cards. To order free campaign materials (including accessible versions), visit https://www.orderline.dh.gov.uk or call 0300 123 1002.

GP services get £100 million boost

NHS England has once again opened the application process for the Prime Minister's Fund.

The £100 million fund is open to bids from GPs wanting to extend access to GP services through improvements such as offering weekend appointments and longer opening hours.

Government urged to act on preventable illness

The Richmond Group of charities has published a report bemoaning the failure to tackle the risk factors that lead to common diseases.

The report issues a call to action to politicians and health service leaders urging them to take more effective steps on preventable diseases.

Time to move from talk to action on reducing preventable illness.
A report by The Richmond Group of Charities
http://www.bhf.org.uk/pdf

Cardiovascular disease profiles NHS England

Public Health England’s National Cardiovascular Intelligence Network cardiovascular disease 211 CCGs in England.

Public Health England’s (PHE) National Cardiovascular Intelligence Network (NCVIN) published its first cardiovascular disease profiles for each of the 211 clinical commissioning groups (CCGs) in England today (5 August 2014). The profiles highlight important facts about these conditions and include information on the leading risk factors such as smoking and obesity.

Following the recommendations of the Cardiovascular Disease Outcomes Strategy to treat coronary heart disease, diabetes, kidney disease and stroke as a single family of conditions, the profiles bring together information about each of these.

Cardiovascular disease is the biggest killer of adults after cancer and is a common reason to premature death. Over recent decades much has already been achieved in reducing the number of people dying from these conditions but many people still experience a reduced quality of life as a result or die prematurely. In 2012 it was recorded that 33,258 people died from heart disease, stroke or vascular disease under the age of 75 years. By using these profiles local areas can identify opportunities for further improvement, building on their success to date while planning to tackle emerging issues such as an aging population and increased levels of obesity.

In coming weeks, as well as the profiles PHE will release an interactive version of the data which allows CCGs to compare themselves with others, including those in their strategic clinical network (SCN). The interactive version of the data will be available in PHE’s Fingertip tool.

The NCVIN is 1 of 5 intelligence networks, with others looking at cancer, mental health dementia and neurology, child and maternal health and end of life. Hosted by PHE, the networks operate across organisations including NHS England, the National Institute for Health and Care Excellence (NICE), local authorities, charities, academic institutions and others. Their aim is to encourage the use of data and information to improve the quality of care and outcomes for communities, patients and their families.

Visit PHE’s data and knowledge gateway to access data and analysis tools from across the organisation.

Accessing and Engaging with NHS England Meeting

Venue: Governors Hall, St Thomas’s Hospital, Westminster Bridge Road, London SE1 7E

Event details:

This one day event, hosted by NHS England and ABHI, is intended for any industry organisations that want to better access and engage with NHS England. This event will:
• Provide participants with advice and guidance on how to engage with the NHS and navigate the new landscape – including how and where to access it
• Stimulate greater opportunities and conversations for collaborative working between NHS England, industry and trade associations
• Bring to life why industry needs to co-design with NHS England and keep NHS utility front of mind when innovating

To Register VIsit: https://www.abhi-events.org.uk/accessing..

Confirmed Speakers

• Miles Ayling, Director of Innovation, NHS England
• Peter Ellingworth, CEO, ABHI
• Lenore Ogilvy, Commercial Specialist, NHS England
• Robert Chesters, Innovation Lead, NHS England
• Johanna Ejbye, AHSN Excellence Lead, NHS England
• Annie Thompson, Collaboration for Excellence Lead, NHS England
• Paul Rice, Head of Technology Strategy, NHS England .

Sessions

Getting to know NHS England
• The new NHS England landscape and our challenges
• Importance of collaboration between the NHS and Industry
• Role of innovation, industry and Innovation, Health and Wealth

Importance of trade associations.

What NHS England is doing to engage industry
• High quality care for all, now and for future generations
• Industry Council and Sector Boards
• Supporting SMEs
• Using Innovation Connect

Understanding NHS England’s “Call to Action” – Future vision and direction

Academic Health Science Networks (AHSNs) and how they support industry

Funding and where to go for it
• Technology Enabled Care Services
• Regional Innovation Fund
• Technology Fund

Event Details:

Date: Thursday 2nd October 2014

Registration: 09.30 with close at 16.00

Venue: St Thomas’s Hospital, Westminster Bridge Road, London SE1 7EH

Cost: £150+VAT Members, £150+VAT Association Members, £195+ VAT for Non-Members.

To Register visit: https://www.abhi-events.org.uk/accessingandengagingwithnhsengland

For more information about all ABHI events please contact:

Jane Sessenwein
ABHI
250 Waterloo Road
London SE1 8RD
Tel: +44 (0)20 7960 4380 Fax: +44 (0)20 7960 4361 Email: jane.sessenwein@abhi.org.uk

Liz Carrington
ABHI
250 Waterloo Road
London SE1 8RD
Tel: +44 (0)20 7960 4368 Fax: +44 (0)20 7960 4361 Email: Liz.Carrington@abhi.org.uk

'Good Surgical Practice' outlines clear standards expected of all surgeons

The Royal College of Surgeons of England today launched Good Surgical Practice outlining clear standards expected of all surgeons.

Standards for surgical practice and achieving high-quality care outlined in new Good Surgical Practice
published by RCS.The Royal College of Surgeons of England today launched Good Surgical Practice outlining clear standards expected of all surgeons.

The guide outlines the skills, values and attitudes that underpin the profession and has been developed with surgeons and patient groups.Good Surgical Practice has been updated following the recent release of the General Medical Council’s re-working of Good Medical Practice and addresses some of the key challenges facing the profession today.

Collaborative working and patient safety shines through as a core message in the guide. In light of the launch of revalidation for all doctors at the beginning of this year, the publication of the Francis Inquiry report in 2013 and increasing focus on quality of care, transparency and professionalism,the guide recommends surgeons should ensure they are effectively working in multidisciplinary teams to improve communication with patients and the decision making process.

Surgical leadership and teamwork are crucial for achieving high-quality patient care and this guide provides surgeons with a model that they should aspire to in day to day practice.

Good Surgical Practice provides guidance around 4 core areas which reflect the four domains of the GMC’s Good Medical Practice:

- Knowledge, skills and performance
- Safety and Quality
- Communication, partnership, teamwork
- Maintaining trust

Miss Clare Marx, President of the Royal College of Surgeons (RCS) said:

Good Surgical Practice is an essential resource for anyone in the profession throughout their careers, as they seek to deliver the best possible outcomes for patients. Surgeons need to be supported to navigate the challenges faced by the profession and deliver the best quality care possible. We should all aspire to the standards outlined in this guide and continue to work together effectively across teams and specialties in the delivery of care.

Miss Clare Marx will be presenting Good Surgical Practice to staff at UHSM, Wythenshawe, Manchester on 10 September 2014.
Access the full copy of Good Surgical Practice here

NHS terms and conditions for procuring goods and services

The NHS terms and conditions are for the use of NHS bodies procuring goods and services from commercial organisations, not for the procurement of clinical services from other NHS bodies or independent sector providers.

The NHS terms and conditions are for the use of NHS bodies procuring goods and services from commercial organisations, not for the procurement of clinical services from other NHS bodies or independent sector providers.

This suite of documents provides guidance notes and associated documentation for contract version and framework agreements for the supply of goods and provision of services.

Link to the PDF documents https://www.gov.uk/government/publications/nhs-standard-terms-and-conditions-of-contract-for-the-purchase-of-goods-and-supply-of-services

CLIENTS
  • Aerocrine UK
  • Airsonett UK
  • Allergy Healthcare UK
  • American Medical Systems Inc
  • Angiodynamics
  • Aquilant Interventional
  • Asalus Medical Instrument UK
  • Atossa Genetics Inc
  • Avinger Inc
  • Bard UK
  • Baxter
  • Bayer UK Ltd
  • BBraun Medical UK
  • Bio2 Medical Inc
  • Carl Zeiss Meditec GmbH
  • CJ Medical UK Ltd
  • Conceptus Inc
  • Coviden UK
  • Cytori Inc
  • Dendite Clinical Systems
  • Dfine Inc
  • Dvsis UK
  • Entellus Medical Inc
  • First Kind Medical
  • Flowmedic Ltd
  • Glaukos Inc
  • Halt Medical Inc
  • Hansen Medical Inc
  • HeartFlow Inc
  • Hologic UK
  • InControl Medical Inc
  • JustRIght Surgical Inc
  • Leeds University Hospital Trust
  • Lina UK
  • Medistim UK
  • Neotract Inc
  • NeuroMetrix Inc
  • North Star
  • Oraya Therapeutics Inc
  • Peezy UK
  • Pulse Surgical UK Ltd
  • Sapheon Inc
  • Second Sight Inc
  • Sequana Medical Inc
  • Seno Medical Inc
  • Sensimed Inc
  • Smith & Nephew UK
  • Southampton University Hospitals NHS Trust
  • SpectraScience Inc
  • SRA Developments UK
  • Straub GmbH
  • Tearlab Inc
  • Tenaxis Medical Inc
  • Torax Inc
  • Transmedics Inc
  • Wellards UK
  • UK Haptics
  • USGI Inc
  • Vascular Graft Solutions
  • Verathon Medical UK
  • Vivo Smart Medical Devices Ltd
Facts And Figures
The NHS
61m +
Potential patients
1m
Patients treated
each day
£ 11.5m
Spent on clinical
research everey day
UK Medical Devices Market
Market valued at
£ 6.4 bn
in 2013
Market forecast to grow by
7.3 %
Per Year
Market expected to reach
£ 9.1 bn
in 2018
Contact us

location_cion

Device Access UK Ltd, Albertine House,
Michelmersh, Hampshire, England S051 OAG
location_cion

+44 1794 329750
location_cion

+44 1794 338333
location_cion

deviceaccess.co.uk

Recents Tweets

CardioKinetix secures $50M in funding, exclusive acquisition deal https://t.co/QUtXl5mJOd
- Tuesday Dec 9 - 4:45pm

LinkedIn Pulse: The day's top news tailored for you http://t.co/HvGKxp1uRg
- Friday Dec 5 - 9:05am

Health and Care Innovation Expo 2015 http://t.co/KHvqSw2Yqe
- Thursday Dec 4 - 7:31pm

Simon Stevens’ response to the HM Treasury’s announcement of additional funding for the NHS http://t.co/OFNZIYAY6n
- Thursday Dec 4 - 8:39am

Patients reporting better experience of A&E http://t.co/NbXzwW2fGn
- Tuesday Dec 2 - 9:06pm

Subscribe to Newsletter


 

Get Social

Accreditations

LinkedIn Auto Publish Powered By : XYZScripts.com